Scavenging, signalling and adhesion coupling in macrophages: Implications for atherogenesis

Current Opinion in Lipidology

Volumn 8, Issue 5, 1997, Pages 287-300

  Schmitz, Gerd ^a   Orsó, Evelyn ^a   Rothe, Gregor ^a   Klucken, Jochen ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; COMPLEMENT RECEPTOR; FC RECEPTOR; INTEGRIN; LIGAND; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL; RECEPTOR; SCAVENGER; UROKINASE;

ANTIGEN PRESENTATION; ATHEROGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL METABOLISM; CELL MIGRATION; COOPERATION; IMMUNE RESPONSE; MACROPHAGE; MONOCYTE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030733115     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199710000-00008     Document Type: Review

References (142)

1. Peters JH, Gieseler R, Thiele B, Steinbach F: Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today 1996, 17:273-278. This paper excellently summarizes that dendritic cells can be developed and differentiated from myeloid precursor forms, and the first steps in the development of macrophages and dendritic cells are common.
2. Rothe G, Holger G, Kovács E, Klucken J, Stöhr J, Kindermann W, Schmitz G: Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996, 16:1437-1447. This paper demonstrates blood monocyte heterogeneity as analysed by immunophenotyping and functional analysis. The five monocyte subsets that can be recently analysed relate to atherogenic risk factors.
3. Malik N, Greenfield BW, Wahl AF, Kiener PA: Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol 1996, 156:3952-3960.
4. Laman JD, de Smet BJGL, Schoneveld A, van Meurs M: CD40-CD40L interactions in atherosclerosis. Immunol Today 1997, 18:272-277. In this excellent paper the authors present putative roles of the local interactions of CD40 and its ligand in multiple processes of different cell types contributing to atherosclerosis.
5. Ross R: Cell biology of atherosclerosis. Annu Rev Physiol 1995, 57:791-804.
6. Dunon D, Piali L, Imhof BA: To stick or not to stick: the new leukocyte homing paradigm. Curr Opin Cell Biol 1996, 8:714-723. This review shows in detail that leukocyte homing occurs in four steps: rolling, triggering, tight adhesion and migration. The molecular interactions are also discussed.
7. Murakami T, Yamada N: Modification of macrophage function and effects on atherosclerosis. Curr Opin Lipidol 1996, 7:320-323.
8. van der Wal AC, Das PK, Tigges AJ, Becker AE: Macrophage differentiation in atherosclerosis: an in situ immunohistochemical analysis in humans. Am J Pathol 1992, 141:161-168.
9. Bhakdi S, Dorweiler B, Kirchmann R, Torzewski J, Weise E, Tranum-Jensen J, Walev I, Wieland E: On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J Exp Med 1995, 182:1959-71
10. Stemme S, Holm J, Hansson GK: T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 1992, 12:206-211.
11. Kannel WB, Anderson K, Wilson PWF: White blood cell count and cardiovascular disease: insights from the Framingham study. JAMA 1992, 267:1253-1256.
12. Heinrich J, Schulte H, Schonfeld R, Köhler E, Assmann G: Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 1995, 73:374-379.
13. Mori T, Sasaki J, Kawaguchi H, Handa K, Takada Y, Matsumaga A, Kono S, Arakawa K: Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J 1995, 129:234-238.
14. Hatanaka K, Li XA, Masuda K, Yutani C, Yamamoto A: Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic lesions by a modified streptavidin-biotin staining method. Pathol Int 1995, 45:635-641.
15. Averill LE, Meagher RC, Gerrity RD: Enhanced monocyte progenitor cell proliferation in bone marrow of hyperlipemic swine. Am J Pathol 1989, 135:369-377.
16. Plump AS, Breslow JL: Apolipoprotein E and the apolipoprotein E-deficient mouse. Annu Rev Nutr 1995, 15:495-518.
17. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M: Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 1995, 92:8264-8268.
18. Boisvert WA, Spangenberg J, Curtiss LK: Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J Clin Invest 1995, 96:1118-1124.
19. Linton MF, Atkinson JB, Fazio S: Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 1995, 267:1034-1037.
20. Bell FP, Gerrity RG: Evidence for an altered lipid metabolic state in circulating blood monocytes under conditions of hyperlipemia in swine and its implication in arterial lipid metabolism. Arterioscler Thromb 1992, 12:155-162.
21. Stragliotto E, Camera M, Postiglione A, Sirtori M, Di Minno G, Tremoli E: Functionally abnormal monocytes in hypercholesterolemia. Arterioscler Thromb 1993, 13:944-950.
22. Hughes DA, Townsend PJ, Haslam PL: Enhancement of the antigen-presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanisms in extrinsic allergic alveolitis and atherosclerosis. Clin Exp Immunol 1992, 87:279-286.
23. Weiss A, Littman DR: Signal transduction by lymphocyte antigen receptors. Cell 1994, 76:263-274.
24. Kiener PA, Rankin BM, Burkhardt AL, Schieven GL, Gilliland LK, Rowley RB, Bolen JB, Ledbetter JA: Cross-linking of Fc gamma receptor I (FCγRI) and receptor II (FcγRII) on monocytic cells activates a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase. J Biol Chem 1993, 268:24442-24448.
25. Rankin BM, Yocum SA, Mittler RS, Kiener PA: Stimulation of tyrosine phosphorylation and calcium mobilization by Fcγ receptor cross-linking. Regulation by the phosphotyrosine phosphatase CD45. J Immunol 1993, 150:605-616.
26. Rothe G, Stöhr J, Fehringer P, Gasche C, Schmitz G: Altered mononuclear phagocyte differentiation associated with genetic defects of the lysosomal acid lipase. Atherosclerosis 1997, 130:215-221. This paper indicates that the genetic defect in lysosomal acid lipase deficiency is associated with an increased fraction of monocytes that expresses higher levels of the immaturity marker CD56 (neural cell adhesion molecule), indicative of a higher flux rate of monocytes through the blood compartment.
27. Hemler ME: VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990, 8:365-400.
28. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25.
29. Weber C, Alon R, Moser B, Springer TA: Sequential regulation of α4β1 and α5β1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis. J Cell Biol 1996, 134:1063-1073.
30. Terui Y, Furukawa Y, Sakai T, Kikuchi J, Sugahara H, Kanakura Y, Kitagawa S, Miura Y: Up-regulation of VLA-5 expression during monocytic differentiation and its role in negative control of the survival of peripheral blood monocytes. J Immunol 1996, 156:1981-88.
31. Flora PK, Gregory CD: Recognition pathways in the interaction of macrophages with apoptotic B cells. In: Leukocyte Typing V. White cell differentiation antigens. Proceedings of the Fifth International Workshop and Conference. Edited by Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF. New York: Oxford University Press; 1995, 2:1675-1677.
32. Springer TA: Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995, 52:827-872.
33. Plow EF, Zhang L: A MAC-1 attack: integrin functions directly challenged in knockout mice [editorial]. J Clin Invest 1997, 99:1145-1146.
34. Lu H, Smith W, Perrard J, Bullard D, Tang LP, Shappell SB, Entman ML: LFA-1 is sufficient in mediating neutrophil emigration in Mac-1 deficient mice. J Clin Invest 1997, 99:1340-1350.
35. Wu MX, Ao Z, Hegen M, Morimoto C, Schlossman SF: Requirement of Fas (CD95), CD45, and CD11a/CD18 in monocyte-dependent apoptosis of human T cells. J Immunol 1996, 157:707-713.
36. Petty HR, Todd RF 3rd: Integrins as promiscuous signal transduction devices. Immunol Today 1996, 17:209-212. This review summarizes the data avalable tor physical and functional cooperation of GPI-linked receptors with β2-integrins.
37. Craig SW, Johnson RP: Assembly of focal adhesions: progress, paradigms, and portents. Curr Opin Cell Biol 1996, 8:74-85.
38. Zigmond SH: Signal transduction and actin filament organization. Curr Opin Cell Biol 1996, 8:66-73.
39. Parsons JT: Integrin-mediated signaling: regulation by tyrosine kinases and small GTP-binding proteins. Curr Opin Cell Biol 1996, 8:146-152.
40. Dedhar S, Hannigan GE: Integrin cytoplasmic interactions and bidirectional transmembrane signalling. Curr Opin Cell Biol 1996, 8:657-669.
41. cbl links c-Src and phosphatidylinositol 3′-kinase to the integrin signaling pathway. J Biol Chem 1997, 272:3780-3787.
42. Shimizu Y, Hunt SW 3rd: Regulating integrin-mediated adhesion: one more function for PI 3-kinase? Immunol Today 1996, 17:565-573.
43. Moolenaar WH, Kranenburg O, Postma FR, Zondag GCM: Lysophosphatidic acid: G-protein signalling and cellular responses. Curr Opin Cell Biol 1997, 9:168-173.
44. Kodama T, Doi T, Suzuki H, Takahashi K, Wada Y, Gordon S: Collagenous macrophage scavenger receptors. Curr Opin Lipidol 1996, 7:287-291.
45. Pearson AM: Scavenger receptors in innate immunity. Curr Opin Immunol 1996, 8:20-28.
46. Krieger M, Herz J: Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor related protein (LRP). Annu Rev Biochem 1994, 63:601-637.
47. Bu G, Rennke S: Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein. J Biol Chem 1996, 271:22218-22224.
48. Willnow TE, Rohlmann A, Horton J, Otani H, Braun JR, Hammer RE, Herz J: RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors. EMBO J 1996, 15:2632-2639.
49. Acton SL, Scherer PE, Lodish HF, Krieger M: Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 1994, 269:21003-21009.
50. Rigotti A, Acton SL, Krieger M: The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 1995, 270:16221-16224.
51. Asch A: To tell the truth: Will the real CD36 please stand up? J Lab Clin Med 1996, 127:321-325.
52. Endeman G, Stauton LW, Madden KS, Bryant CM, White RT, Protier AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993, 268:11811-11816.
53. Silverstein RL, Asch AS, Nachman RL: Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest 1989, 84:546-552.
54. Puente Navazo MD, Daviet L, Savill J, Ren Y, Leung LLK, McGregor JL: Identification of a domain (155-183) on CD36 implicated in the phagocytosis of apoptotic neutrophils. J Biol Chem 1996, 271:15381-15385.
55. Huang MM, Bolen JB, Barnwell JW, Shuttil SJ, Brugge JS: Membrane glycoprotein IV (CD36) is physically associated with the fyn, lyn and yes protein tyrosine kinases in human platelets. Proc Natl Acad Sci U S A 1991, 88:7844-7848.
56. Asch AS, Liu I, Briccetti FM, Barnwell JW, Kwakye-Berko F, Dokun A, Goldberger J, Pernambuco M: Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain. Science 1993, 262:1436-1440.
57. Puente Navazo MD, Daviet L, Ninio E, McGregor JL: Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler Thromb Vasc Biol 1996, 16:1033-1039.
58. Ren Y, Silverstein RL, Allen J, Savill J: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995, 181:1857-1862.
59. Mikhailenko I, Krylov D, McTigue Argraves K, Roberts DD, Liau G, Strickland DK: Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). J Biol Chem 1997, 272:6784-6791. This paper shows that internalization of TSP-1 is mediated by the NH2-terminal heparin-binding domain that interacts with LHP for clearance.
60. Asch AS, Silbiger S, Heimer E, Nachman RL: Thrombospondin sequence motiv (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun 1992, 182:1208-1217.
61. Catimel B, Leung L, el-Ghissasi H, Mercier N, McGregor J: Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motiv), but not to the N-terminal heparin-binding region. Biochem J 1992, 284:231-236.
62. Pearce SFA, Wu J, Silverstein RL: Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. Evidence for a single calcium-dependent binding site on CD36. J Biol Chem 1995, 270:2981-2986.
63. Leung LL, Li W-X, McGregor JL, Albrecht G, Howard RJ: CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction. J Biol Chem 1992, 267:18244-18250.
64. Gao A-G, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA: Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 1996, 271:21-24.
65. 3 function through integrin-associated protein. J Cell Biol 1996, 135:533-544.
66. Sitrin RG, Todd RF 3rd, Petty HR, Brock TG, Schollenberger SB, Albrecht E, Gyetko MR: The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest 1996, 97:1942-51. The authors demonstrate that complex formation of uPARs and integrins facilitate the adhesive functions of CR3. This function of uPAR is independent from its occupancy, which impairs adhesion.
67. Rao NK, Shi G- P, Chapman HA: Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression. J Clin Invest 1995, 96:465-474.
68. Higazi AA- R, Aceto JF, Kniss D, Upson R, Cohen R, Dichek DA, Cines DB: Unesterified long chain fatty acids inhibit the binding of single chain urokinase to the urokinase receptor. Biochemistry 1996, 35:6884-6890.
69. Simon DI, Rao NK, Xu H, Wei Y, Majdic O, Ronne E, Kobzik L, Chapman HA: Mac 1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood 1996, 88:3185-3194.
70. Wei Y, Lukashev M, Simon DI, Bodory SC, Rosenberg S, Doyle MV, Chapman HA: Regulation of integrin function by the urokinase receptor. Science 1996, 273:1551-1555.
71. Kindzelskii AL, Laska ZO, Todd RF 3rd, Petty HR: Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (αMβ2, CD11b/CD18) during neutrophil polarization. J Immunol 1996, 156:297-309.
72. Kim S-O, Plow EF, Miles LA: Regulation of plasminogen receptor expression on monocytoid cells by β1-integrin-dependent cellular adherence to extracellular matrix proteins. J Biol Chem 1996, 271:23761-23767.
73. Yu B, Hailman E, Wright SD: Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 1997, 99:315-324. This article demonstrates that LPS acts as a phospholipid exchange protein for anionic phospholipids.
74. Zarewych DM, Kindzelskii AL, Todd RF 3rd, Petty HR: LPS induces CD14 association with complement receptor type 3, which is reversed by neutrophil adhesion. J Immunol 1996, 156:430-433.
75. Wright SD, Levin SM, Jong MT, Chad Z, Kabbash LG: CR3 (CD11b/CD18) expresses one binding site for Arg-Gly Asp-containing peptides and a second site for bacterial lipopolysaccharide. J Exp Med 1989, 169:175-183.
76. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
77. Wright SD, Ramos RA, Hermanowsky-Vosatka A, Rockwell P, Detmers PA: Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J Exp Med 1991, 173:1281-1286.
78. Han J, Lee JD, Tobias PS, Ulevitch RJ: Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem 1993, 268:25009-25014.
79. Detmers PA, Zhou D, Powell DE: Different signaling pathways for CD18-mediated adhesion and Fc-mediated phagocytosis. Response of neutrophils to LPS. J Immunol 1994, 153:2137-2145.
80. Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM, Wright SD: Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994, 179:269-277.
81. Ingalls RR, Golenbock DT: CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med 1995, 181:1473-1479.
82. Gegner JA, Ulevitch RJ, Tobias PS: Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 1995, 270:5320-5325.
83. Jones SL, Brown EJ: Functional cooperation between Fc (receptors and complement receptors in phagocytes. In Human IgG Fc receptors. Edited by van de Winkel JGJ, Capel PJA. Austin: RG Landes Company, 1996: 149-163.
84. Ravetch JV: Fc receptors: rubor redux. Cell 1994, 78:553-560.
85. Strzelecka A, Kwiatkowska K, Sobota A: Tyrosine phosphorylation and Fcγ receptor-mediated phagocytosis. FEBS Lett 1997, 400:11-14. Excellent comprehensive review of FcγR signaling.
86. Gessner JE, Grussenmeyer T, Kolanus W, Schmidt RE: The human low affinity immunoglobulin G Fc receptor III-A and III-B genes. Molecular characterization of the promoter regions. J Biol Chem 1995, 270:1350-1361.
87. Gessner JE, Grussenmeyer T, Dumbsky M, Schmidt RE: Separate promoters from proximal and medial control regions contribute to the natural killer cell-specific transcription of the human FcγRIII-A (CD16-A) receptor gene. J Biol Chem 1996, 271:30755-30764.
88. Galon J, Gauchat JF, Maziéres N, Spagnoli R, Storkus W, Lötze M, Bonnefoy JY, Fridman WH, Sautés C: Soluble Fcγ receptor type III (FcγRIII, CD16) triggers cell activation through interaction with complement receptors. J Immunol 1996, 157:1184-1192.
89. 2 integrin Mac-1 but not p150,95 associates with FcγRIIA. Eur J Immunol 1996, 26:207-212.
90. Greenberg S, Chang P, Silverstein SC: Tyrosine phosphorylation of the gamma subunit of Fc gamma receptors, p72syk, and paxillin during Fc receptor-mediated phagocytosis in macrophages. J Biol Chem 1994, 269:3897-3902.
91. Nada S, Okada M, Aizawa S, Nakagawa H: Identification of major tyrosine-phosphorylated proteins in Csk-deficient cells. Oncogene 1994, 9:3571-3578.
92. Ninomiya N, Hazeki K, Fukui Y, Seya T, Okada T, Hazeki O, Ui M: Involvement of phosphatidylinositol 3-kinase in Fc gamma receptor signaling. J Biol Chem 1994, 269:22732-22737.
93. Liao F, Shin HS, Rhee SG: Tyrosine phosphorylation of phospholipase C-gamma 1 induced by cross-linking of the high-affinity or low-affinity Fc receptor for IgG in U937 cells. Proc Natl Acad Sci U S A 1992, 89:3659-3663.
94. Darby C, Geahlen RL, Schreiber AD: Stimulation of macrophage Fc gamma RIIIA activates the receptor-associated protein tyrosine kinase Syk and induces phosphorylation of multiple proteins including p95Vav and p62/GAP-associated protein. J Immunol 1994, 152:5429-5437.
95. Oren R, Takahashi S, Doss C, Levy R, Levy S: TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol 1990, 10:4007-4015.
96. Horejsi V, Vicek C: Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS Lett 1991, 288:1-4.
97. Metzelaar MJ, Wijngaard PL, Peters PJ, Sixma JJ, Nieuwenhuis HK, Clevers HC: CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 1991, 266:3239-3245.
98. Hotta H, Ross AH, Huebner K, Isobe M, Wendeborn S, Chao MV, Ricciardi RP, Tsujimoto Y, Croce CM, Koprowski H: Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res 1988, 48:2955-2962.
99. Amiot M: Identification and analysis of cDNA clones encoding CD53. A pan-leukocyte antigen related to membrane transport proteins. J Immunol 1990, 145:4322-4325.
100. Mawby WJ, Holmes CH, Anstee DJ, Spring FA, Tanner MJ: Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3. Biochem J 1994, 304:525-530. This paper characterizes CD47, a member of the four-transmembrane domain protein family, as an integrin-associated protein. This protein may play an important role in functional cooperation of the TSPR (CD36) and integrins.
101. Campbell IG, Freemont PS, Foulkes W, Trowsdale J: An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res 1992, 52:5416-5420.
102. Brown E, Hooper L, Gresham H: Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol 1990, 111:2785-2794.
103. Messika EJ, Avni O, Gallily R, Yefenof E, Baniyash M: Identification and characterization of a novel protein associated with macrophage complement receptor 3. J Immunol 1995, 154:6563-6570.
104. Noda-Heiny H, Daugherty A, Sobel BE: Augmented urokinase receptor expression in atheroma. Arterioscler Thromb Vasc Biol 1995, 15:37-43.
105. Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Farzioli F: Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J 1996, 15:1572-1582.
106. Cao D, Mizukami IF, Garni-Wagner BA, Kindzelskii AL, Todd RF 3rd, Boxer LA, Petty HR: Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium. J Immunol 1995, 154:1817-1829.
107. Almus-Jacobs F, Varki N, Sawdey MS, Loskutoff DJ: Endotoxin stimulates expression of the murine urokinase receptor gene in vivo. Am J Pathol 1995, 147:688-698.
108. Okada SS, Grobmyer SR, Barnathan ES: Contrasting effects of plasminogen activators, urokinase receptor and LDL receptor related protein on smooth muscle cell migration and invasion. Arterioscler Thromb Vasc Biol 1996, 16:1269-1276.
109. Faisal Khan KM, Falcone DJ: Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression. J Biol Chem 1997, 272:8270-8275.
110. Ritchie H, Jamieson A, Booth NA: Peripheral blood monocyte synthesis of plasminogen activator inhibitor 2 in response to native and modified LDL. Thromb Haemost 1995, 74:1521-1527.
111. Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA, Gliemann J, Christensen EI, Blasi F: α2-macroglobulin receptor/Ldl receptor-related protein (Lrp)-dependent internalization of the urokinase receptor. J Cell Biol 1995, 131:1609-1622. This paper demonstrates that LDL receptor-related protein is involved in the internalization of the uPAH to facilitate lysosomal clearance of uPA/PAI-complexes.
112. Hampton RY, Golenbock TD, Penman M, Krieger M, Raetz CR: Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991, 352:342-344.
113. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T et al.: A role for macrophage receptors in atherosclerosis and susceptibility to infection. Nature 1997, 386:292-296. The first description of M (type-I and type-II) SR-A knock-out mice. Target disruption of SRA gene results in the reduction in lesion-size in an animal deficient in apoE, leads to increased susceptibility to infection and causes impaired macrophage adhesion.
114. Ulevitch RJ, Johnston AR, Weinstein DB: New function for high density lipoproteins: isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. J Clin Invest 1981, 67:827-837.
115. Munford RS, Andersen JM, Dietschy JM: Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey. J Clin Invest 1981, 68:1503-1513.
116. Munford RS, Hall CL, Dietschy JM: Binding of Salmonella typhimurium lipopolysaccharides to rat high density lipoproteins. Infect Immun 1981, 34:835-843.
117. Parker TS, Levine DM, Chang JCC, Laxer J, Coffin CC, Rubin AL: Reconstituted high density lipoprotein neutralizes Gram negative bacterial lipopolysaccharides in human whole blood. Infect Immun 1995, 63:253-258.
118. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL: In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci U S A 1993, 90:12040-12044.
119. Tobias PS, Ulevitch RJ: Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein. J Immunol 1983, 131:1913-16.
120. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD: Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994, 180:1025-1035.
121. Emancipator K, Csako G, Elin RJ: In vitro inactivation of bacterial endotoxins by human lipoproteins and apolipoproteins. Infect Immun 1992, 60:596-601.
122. Hailman E, Albers JJ, Wolfbauer G, Tu A-Y, Wright SD: Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J Biol Chem 1996, 271:12172-12178. This paper shows that phospholipid transfer protein is able to mediate the exchange of LPS between micelles and transfer of LPS to HDL particles. Phospholipid transfer protein is not involved in transfer of LPS to CD14 or, therefore, in mediation of cell response to LPS.
123. Park CT, Wright SD: Plasma lipopolysaccharide binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins. J Biol Chem 1996, 271:18054-18060. This paper characterizes an apoA-I containing HDL particle that is associated with LBP and factor H-related protein as a major component.
124. Massamiri T, Tobias PS, Curtiss LK: Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I. J Lipid Res 1997, 38:516-525.
125. Calvo D, Vega MA: Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 1993, 268:18929-18935.
126. Fukasawa M, Adachi H, Hirota K, Tsujimoto M, Arai H, Inoue K: SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp Cell Res 1996, 222:246-250.
127. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996, 271:518-520.
128. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y, Nakata A, Ishigami M, Miyagawa J, Kameda-Takemura K et al.: Reduced uptake of oxidized LDL in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest 1995, 96:1859-1865.
129. 3 (CD36) thrombospondin recognition mechanism and lack of phlogistic response. Am J Pathol 1996, 149:911-921.
130. Ren Y, Savill J: Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neurtophils undergoing apoptosis. J Immunol 1995, 154:2366-2374.
131. Godyna S, Liau G, Popa I, Stefansson S, Argraves WS: Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1. J Cell Biol 1995, 129:1403-1410.
132. Kiener PA, Rankin BM, Davis PM, Yocum SA, Warr GA, Grove RI: Immune complexes of LDL induce atherogenic responses in human monocytic cells. Arterioscler Thromb Vasc Biol 1995, 15:990-999.
133. Mironova M, Virella G, Lopes Virella MF: Isolation and characterization of human antioxidized LDL autoantibodies. Arterioscler Thromb Vasc Biol 1996, 16:222-229.
134. Huang Y, Gosh MJ, Lopes Virella MF: Transcriptional and posttranscriptional regulation of LDL receptor gene expression in PMA treated THP1 cells by LDL containing immune complexes. J Lipid Res 1997, 38:110-120.
135. McNally AK, Anderson JMC: Complement C3 participation in monocyte adhesion to different surfaces. Proc Natl Acad Sci U S A 1994, 91:10119-10123.
136. Torzewski J, Oldroyd R, Lachmann P, Fitzsimmons C, Proudfoot D, Bowyer D: Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol 1996, 16:673-677.
137. Guyton JR, Klemp KF: Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 1996, 16:4-11.
138. Sutterwala FS, Rosenthal LA, Mosser DM: Cooperation between CR1 (CD35) and CR3 (CD11b/CD18) in the binding of complement-opsonized particles. J Leukoc Biol 1996, 59:883-890.
139. Wong WW, Klickstein LB, Smith JA, Weis JH, Fearon DT: Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4b. Proc Natl Acad Sci U S A 1985, 82:7711-7715.
140. Ezekowitz RAB, Sim RB, MacPherson GG, Gordon S: Interaction of human monocytes, macrophages and polymorphonuclear leukocytes with zymosan in vitro. J Clin Invest 1985, 76:2368-2376.
141. Mosser DM, Edelson PJ: The mouse macrophage receptor for iC3b (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. J Immunol 1985, 135:2785-2789.
142. Bonnefoy JY, Plater-Zyberk C, Lecoanet-Henchoz S, Gauchat JF, Aubry JP, Graber P: A new role for CD23 in inflammation. Immunol Today 1996, 17:418-420.